The Risk of Exacerbation of Chronic Hepatitis B After Percutaneous Radiofrequency Ablation of Hepatocellular Carcinoma
It has been reported that HBV replication can be reacted after chemotherapy or
immunotherapy, which will lead to exacerbation of chronic hepatitis B (ECHB). It is still
unknown that if percutaneous radiofrequency ablation or liver resection for hepatocellular
carcinoma (HCC) will react the replication of HBV or not. This study aim to find out the
risk of exacerbation of chronic hepatitis B after percutaneous radiofrequency ablation (RFA)
or hepatectomy for HCC, and it's effect to treatment outcome.
Observational
Observational Model: Case-Only, Time Perspective: Prospective
The Rate of Exacerbation of chronic hepatitis B after RFA
one week, one month, one year
No
min-shan chen, MD
Principal Investigator
Department of Hepatobilliary Surgery, Cancer Center, Sun Yat-sen University
China: Ministry of Health
RFA006
NCT00720668
June 2006
May 2010
Name | Location |
---|